Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Effects on Recovery in Supratentorial Tumor Patients
NCT02007798Unknown
- Sponsor
- China Medical University
- Start
- Jan 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in brain neoplasm (3 arms), sponsored by China Medical University. Primary endpoint: Hemodynamic impacts. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
brain neoplasm
Beyond the preview
Go deeper on NCT02007798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02007798.